- Effectiveness of Rituximab in Pediatric OMS Patients.
- Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)
- Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome
Clinical Trials
- A Clinical Study of Curcuminoids in the Treatment of Oral Lichen Planus
- A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral Lichen Planus
- A Randomized Clinical Trial of the Effect of Pimecrolimus Cream 1% Compared With Topical Corticosteroid in Treatment of Erosive Oral Lichen Planus
- A Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Curcuminoids in Oral Lichen Planus
- Adjunctive Oral Systemic Vitamin E Therapy on Salivary Nitric Oxide Level in Patients With Erosive Oral Lichen Planus
- Apremilast – Oral Lichen Planus Trial
- Association of Oral Lichen Planus and Thyroid Disease
- Based on Metabonomics Dryness Pathogen Type of OLP: a Dynamic Study
- Chamaemelum Nobile 2% Versus Placebo Topic Gel to Treat Oral Lichen Planus
- Clinical and Biochemical Assessment of the Effect of Topical Use of Coenzyme Q10 Versus Topical Corticosteroid in Management of Symptomatic Oral Lichen Planus: Randomized Controlled Clinical Trial
- Clinical and Immunohistochemical Effect of Topical Pimecrolimus in Treatment of Oral Lichen Planus
- Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus
- Comparison of Triamcinolone Acetonide Mucoadhesive Film and Licorice Mucoadhesive Film Effect on Lichen Planus
- Dexamethasone Solution for the Treatment of Oral Lichen Planus
- Dexamethasone to Treat Oral Lichen Planus
- Dual-light Antibacterial Photodynamic Therapy as an Adjunctive Treatment to Triamcinolone in OLP
- Effect of Adjunctive Systemic Vitamin E on Clinical Parameters and Salivary Total Antioxidant Capacity in Symptomatic Oral Lichen Planus Patients: Randomized-controlled Clinical Trial
- Effect of Bifidobacterium Animalis Subsp. Lactis HN019 on Oral Lichen Planus
- Effect of Oral Zinc Supplementation as an Adjuvant to Topical Corticosteroid in Oral Lichen Planus Patients
- Efficacy of Green Tea Buccal Tablets in Oral Lichen Planus
- Efficacy of Intralesional Injection of Platelet Rich Plasma in the Treatment of Patients With Erosive Oral Lichen Planus
- Efficacy of Topical Rapamycin to Treat Chronic Erosive Oral Lichen
- Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen Planus
- Evaluation of Mucoadhesive Tacrolimus Patch on Caspase-3 Inducing Apoptosis in Oral Lichen Planus
- Evaluation of Salivary Level of miR-155 and IL-10 in Oral Lichen Planus Patients Before and After Treatment With Topical Corticosteroid
- Evaluation of Topical Chamomile Versus Topical Triamcinolone Acetonide in Management of Oral Lichen Planus
- Evaluation of Topical Pomegranate Extracts in Management of Oral Lichen Planus (A Randomized Clinical Trial)
- Expression of miRNa-138 and Cyclin D1 in Oral Mucosa of Patients With Oral Lichen Planus
- Glucosamine as a Novel Adjunctive Therapy in Oral Lichen Planus
- Intra-oral Treatment of OLP With Rivelin®-CLO Patches
- Management of Pain in Oral Lichen Planus
- Matrix Metalloproteinases Neutralizing Agents in Oral Lichen Planus
- Micronutrients in Management of Symptomatic Oral Lichen Planus
- Molecular & Cellular Characterisation of Oral Lichen Planus
- Oral Lichen Planus Treatment
- Pimecrolimus Cream for Oral Lichen Planus
- Prolactin Hormone in Oral Lichen Planus
- Relationship Between Oral Lichen Planus and Autoimmune Thyroid Diseases
- Study of Metronidazole and Doxycycline to Treat Oral Lichen Planus and to Compare Their Efficacy With Each Other
- Tacrolimus Ointment in Oral Lichen Planus
- The Association Between Diabetes Mellitus, Oral Lichen Planus and Insulin-like Growth Factors 1 and 2 (IGF1 and IGF2)
- The Effect of Topical Curcumin Versus Topical Corticosteroid on Management of Oral Lichen Planus Patients
- The Efficacy of Omega-3 in Treatment of Atrophic/Erosive Lichen Planus
- The Efficacy of Topical Minocycline in Managing Symptomatic Oral Lichen Planus
- The Efficacy of Topical Sesame Oil Versus Topical Triamcinolone on Oral Lichen Planus and Salivary Level of Oxidative Stress Biomarker [MDA]
- Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus
- Topical “Non-Aromatic Very Rich in Steranes” (NAVS) Naphthalan for the Treatment of Oral Mucosal Diseases
- Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus
- Treatment Modalities of Oral Lichen Planus
- Use of Injectable Platelet Rich Fibrin in Lichen Planus
- A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma
- A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma
- A Study to Evaluate the Efficacy of Neoadjuvant DaRT for Advanced Oral Cavity SCC
- Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck.
- Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A Diagnostic Study
- Biofeedback Rehabilitation to Improve Speaking and Eating in Public
- Camrelizumab Plus Docetaxel and Cisplatin in Recurrent or Metastatic Oral Squamous Cell Carcinoma Patients
- Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I Trial
- Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
- Determination of ALDH1b1 and ALDH2 Polymorphisms Frequency in the Brazilian Population
- Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
- Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma
- Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line
- Efficacy and Safety of Neoadjuvant Pembrolizumab in III -IVA Resectable Oral Squamous Cell Carcinoma
- Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity
- First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
- Ganetespib Window of Opportunity Study in Head and Neck Cancers
- Human Papillomavirus on Oral Tissue, Saliva and Serum
- Identification of Breath Biomarkers in Head and Neck Squamous Cell Carcinoma
- Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer
- IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma
- Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer
- Molecular Mechanisms of the Development of Precancerous and Cancerous Lesions of the Oral Cavity
- Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
- Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma
- Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients
- Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)
- Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Oral Cavity Squamous Cell Carcinoma
- Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery
- NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery
- One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma
- Optimisation of Potential Dental Implant Sites Protection for Rehabilitation in Patients With Head and Neck Cancer: Impact of Virtual Implants Visualisation on Dosimetry (OPPIDOM)
- Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer
- Pembrolizumab Alone or in Combination With Ipatasertib for the Treatment of Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
- Pembrolizumab and Radiation Therapy Before and During Surgery for the Treatment of Persistent or Recurrent Head and Neck Cancer
- Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).
- Postoperative Radiotherapy for Oral Squamous Cell Carcinoma After Neoadjuvant Therapy and Surgery
- Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer
- Radioguided Selective Neck Dissection for Staging and Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
- Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma
- Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery
- Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer
- Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPC
- Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Added to Radiation or Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- Toluidine Blue Versus Frozen Sections for Assessment of Tumor Margins in Oral Squamous Cell Carcinoma
- TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma
- Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC
- Comparative Effect of Nigella Sativa and Conventional Management for OSMF
- Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis
- Efficacy of Curcumin in Oral Submucous Fibrosis
- Epithelial Mesenchymal Transition Markers in OSMF
- Evaluation of Auto Antibodies in Oral Sub Mucous Fibrosis
- Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study
- Topical Application of Curcumin Orabase in Oral Submucous Fibrosis (OSMF)
- Use of Single Staged Nasolabial Flap in Oral Submucous Fibrosis
- A Study to Assess Plasma Ammonia Time-Normalized Area Under the Curve and Rate of Ureagenesis in Healthy Adult Subjects
- Halting Ornithine Transcarbamylase Deficiency With Recombinant AAV in ChildrEn
- Hepatic Histopathology in Urea Cycle Disorders
- Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders
- Investigation of Brain Nitrogen in Partial Ornithine Transcarbamylase Deficiency (OTCD) Using 1 H MRS, DTI, and fMRI
- Liver Disease in Urea Cycle Disorders
- Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency
- Neurologic Injuries in Adults With Urea Cycle Disorders
- Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase Deficiency
- Phase I Study of Adenoviral Vector Mediated Gene Transfer for Ornithine Transcarbamylase in Adults With Partial Ornithine Transcarbamylase Deficiency
- Safety and Dose-Finding Study of DTX301 (scAAV8OTC) in Adults With Late-Onset OTC Deficiency
- Safety, Tolerability and Pharmacokinetics of ARCT-810 in Healthy Adult Subjects
- Safety, Tolerability and PK/PD Evaluation of Intravenous Administration of MRT5201 in Patients With OTC Deficiency
- Safety, Tolerability, and Pharmacokinetics of ARCT-810 in Stable Adult Subjects With OTC Deficiency
- Study for Adolescent and Adult Participants With Ornithine Transcarbamylase Deficiency to Evaluate Safety and Tolerability of ARCT-810
- Study to Characterize Rate of Ureagenesis in Patients With Ornithine Transcarbamylase (OTC) Deficiency
- The NIH UNI Study: Urea Cycle Disorders, Nutrition and Immunity